Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
Price:
10.94
CNY
-1.44%
Market Closed
Market Cap:
¥4.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
|
CN |
|
Jiashili Group Ltd
HKEX:1285
|
CN |
|
T
|
Theriva Biologics Inc
AMEX:TOVX
|
US |
|
Xiaomi Corp
HKEX:1810
|
CN |
|
Meggitt PLC
LSE:MGGT
|
UK |
|
B
|
Bajaj Housing Finance Ltd
NSE:BAJAJHFL
|
IN |
|
Raymond James Financial Inc
NYSE:RJF
|
US |
|
S
|
Sino Biopharmaceutical Ltd
OTC:SBHMY
|
HK |
|
R
|
Rumere Co Ltd
SZSE:301088
|
CN |
Income Statement
Earnings Waterfall
Zhejiang Starry Pharmaceutical Co Ltd
Zhejiang Starry Pharmaceutical Co Ltd
Income Statement
Zhejiang Starry Pharmaceutical Co Ltd
Zhejiang Starry Pharmaceutical Co Ltd
Currency: CNY
| Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
37
|
0
|
0
|
0
|
25
|
0
|
0
|
0
|
34
|
0
|
0
|
0
|
65
|
18
|
36
|
0
|
83
|
39
|
43
|
66
|
92
|
90
|
86
|
84
|
74
|
70
|
77
|
80
|
93
|
103
|
84
|
103
|
79
|
102
|
92
|
96
|
93
|
90
|
0
|
|
| Revenue |
696
N/A
|
661
-5%
|
691
+4%
|
716
+4%
|
673
-6%
|
698
+4%
|
712
+2%
|
712
+0%
|
711
0%
|
712
+0%
|
742
+4%
|
793
+7%
|
891
+12%
|
988
+11%
|
1 098
+11%
|
1 242
+13%
|
1 309
+5%
|
1 306
0%
|
1 395
+7%
|
1 370
-2%
|
1 367
0%
|
1 440
+5%
|
1 500
+4%
|
1 631
+9%
|
2 000
+23%
|
2 153
+8%
|
2 087
-3%
|
2 066
-1%
|
2 131
+3%
|
2 180
+2%
|
1 867
-14%
|
2 196
+18%
|
1 754
-20%
|
2 443
+39%
|
2 370
-3%
|
2 350
-1%
|
2 394
+2%
|
2 418
+1%
|
2 391
-1%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(438)
|
(415)
|
(433)
|
(447)
|
(417)
|
(441)
|
(450)
|
(446)
|
(445)
|
(455)
|
(465)
|
(490)
|
(532)
|
(603)
|
(659)
|
(746)
|
(751)
|
(743)
|
(771)
|
(752)
|
(767)
|
(823)
|
(889)
|
(1 003)
|
(1 255)
|
(1 421)
|
(1 445)
|
(1 503)
|
(1 629)
|
(1 728)
|
(1 466)
|
(1 688)
|
(1 346)
|
(1 896)
|
(1 864)
|
(1 920)
|
(1 977)
|
(1 986)
|
(1 937)
|
|
| Gross Profit |
258
N/A
|
247
-4%
|
258
+5%
|
269
+4%
|
256
-5%
|
257
+0%
|
262
+2%
|
267
+2%
|
266
0%
|
257
-3%
|
277
+8%
|
304
+9%
|
359
+18%
|
385
+7%
|
439
+14%
|
496
+13%
|
558
+12%
|
564
+1%
|
624
+11%
|
617
-1%
|
600
-3%
|
617
+3%
|
611
-1%
|
628
+3%
|
745
+19%
|
732
-2%
|
642
-12%
|
563
-12%
|
503
-11%
|
452
-10%
|
401
-11%
|
508
+27%
|
408
-20%
|
547
+34%
|
506
-7%
|
430
-15%
|
417
-3%
|
432
+4%
|
454
+5%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(129)
|
(129)
|
(136)
|
(140)
|
(142)
|
(138)
|
(136)
|
(136)
|
(142)
|
(133)
|
(136)
|
(145)
|
(180)
|
(175)
|
(198)
|
(200)
|
(215)
|
(230)
|
(230)
|
(241)
|
(243)
|
(239)
|
(251)
|
(255)
|
(280)
|
(280)
|
(296)
|
(317)
|
(345)
|
(463)
|
(383)
|
(357)
|
(280)
|
(380)
|
(378)
|
(369)
|
(375)
|
(391)
|
(400)
|
|
| Selling, General & Administrative |
(73)
|
(113)
|
(120)
|
(123)
|
(78)
|
(137)
|
(133)
|
(122)
|
(79)
|
(125)
|
(130)
|
(125)
|
(102)
|
(125)
|
(123)
|
(141)
|
(112)
|
(133)
|
(137)
|
(141)
|
(136)
|
(160)
|
(166)
|
(159)
|
(144)
|
(171)
|
(187)
|
(204)
|
(206)
|
(217)
|
(156)
|
(211)
|
(180)
|
(255)
|
(255)
|
(235)
|
(248)
|
(248)
|
(261)
|
|
| Research & Development |
(40)
|
0
|
0
|
0
|
(49)
|
0
|
0
|
(12)
|
(53)
|
0
|
0
|
(26)
|
(51)
|
(57)
|
(78)
|
(65)
|
(62)
|
(75)
|
(76)
|
(83)
|
(70)
|
(99)
|
(105)
|
(113)
|
(101)
|
(128)
|
(133)
|
(138)
|
(110)
|
(139)
|
(110)
|
(110)
|
(102)
|
(132)
|
(129)
|
(116)
|
(128)
|
(140)
|
(134)
|
|
| Depreciation & Amortization |
(14)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(33)
|
0
|
0
|
0
|
(46)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(55)
|
0
|
0
|
0
|
(49)
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(53)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(1)
|
(16)
|
(16)
|
(17)
|
(2)
|
(2)
|
(3)
|
(3)
|
5
|
(8)
|
(6)
|
6
|
6
|
8
|
4
|
6
|
4
|
(22)
|
(18)
|
(17)
|
12
|
20
|
20
|
18
|
21
|
18
|
23
|
25
|
19
|
(107)
|
(117)
|
14
|
2
|
8
|
5
|
34
|
1
|
(4)
|
(5)
|
|
| Operating Income |
129
N/A
|
118
-8%
|
122
+3%
|
129
+6%
|
114
-12%
|
119
+4%
|
126
+6%
|
131
+4%
|
124
-5%
|
124
0%
|
142
+15%
|
159
+12%
|
179
+13%
|
210
+17%
|
241
+15%
|
296
+23%
|
343
+16%
|
334
-2%
|
393
+18%
|
376
-4%
|
357
-5%
|
379
+6%
|
361
-5%
|
374
+4%
|
465
+25%
|
452
-3%
|
345
-24%
|
246
-29%
|
157
-36%
|
(11)
N/A
|
17
N/A
|
150
+765%
|
128
-15%
|
167
+30%
|
127
-24%
|
61
-52%
|
42
-31%
|
41
-3%
|
54
+33%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(35)
|
(33)
|
(28)
|
(25)
|
(19)
|
(22)
|
(26)
|
(32)
|
(18)
|
(23)
|
(19)
|
(21)
|
(50)
|
(60)
|
(73)
|
(99)
|
(86)
|
(95)
|
(101)
|
(73)
|
(64)
|
(66)
|
(46)
|
(56)
|
(62)
|
(39)
|
(63)
|
(83)
|
(113)
|
(124)
|
(93)
|
(101)
|
(95)
|
(124)
|
(105)
|
(105)
|
(99)
|
(81)
|
(81)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(2)
|
0
|
(1)
|
(1)
|
(26)
|
0
|
(0)
|
(0)
|
1
|
(1)
|
(3)
|
(4)
|
(3)
|
1
|
3
|
4
|
(100)
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
(10)
|
(0)
|
0
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
(5)
|
(4)
|
(2)
|
(2)
|
(2)
|
0
|
(1)
|
0
|
(3)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
|
| Total Other Income |
4
|
4
|
3
|
6
|
6
|
6
|
6
|
6
|
0
|
(4)
|
(5)
|
(12)
|
(4)
|
(8)
|
(7)
|
(5)
|
(3)
|
(9)
|
(10)
|
(9)
|
11
|
10
|
9
|
9
|
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
(9)
|
(5)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
(3)
|
(5)
|
(7)
|
|
| Pre-Tax Income |
93
N/A
|
85
-9%
|
95
+12%
|
108
+13%
|
97
-10%
|
102
+5%
|
105
+3%
|
104
0%
|
104
-1%
|
95
-8%
|
116
+22%
|
125
+7%
|
119
-5%
|
143
+20%
|
159
+12%
|
191
+20%
|
222
+16%
|
231
+4%
|
283
+23%
|
294
+4%
|
304
+3%
|
322
+6%
|
321
0%
|
323
+1%
|
395
+22%
|
408
+3%
|
280
-31%
|
161
-43%
|
(65)
N/A
|
(148)
-126%
|
(86)
+42%
|
45
N/A
|
31
-32%
|
40
+30%
|
19
-53%
|
(57)
N/A
|
(60)
-4%
|
(46)
+23%
|
(34)
+26%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(20)
|
(21)
|
(18)
|
(24)
|
(22)
|
(24)
|
(23)
|
(22)
|
(22)
|
(20)
|
(24)
|
(30)
|
(23)
|
(26)
|
(31)
|
(36)
|
(39)
|
(41)
|
(49)
|
(45)
|
(50)
|
(53)
|
(62)
|
(60)
|
(66)
|
(57)
|
(34)
|
(21)
|
(7)
|
(1)
|
(2)
|
(1)
|
(9)
|
(7)
|
(5)
|
8
|
12
|
3
|
5
|
|
| Income from Continuing Operations |
74
|
64
|
77
|
84
|
76
|
78
|
82
|
83
|
81
|
75
|
92
|
95
|
96
|
116
|
128
|
155
|
183
|
190
|
233
|
249
|
254
|
269
|
259
|
263
|
330
|
352
|
246
|
140
|
(72)
|
(149)
|
(88)
|
45
|
22
|
33
|
15
|
(49)
|
(47)
|
(43)
|
(29)
|
|
| Income to Minority Interest |
(5)
|
(5)
|
(4)
|
(3)
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
(2)
|
(4)
|
(6)
|
(9)
|
(13)
|
(14)
|
(16)
|
(17)
|
(15)
|
(11)
|
(4)
|
(3)
|
(6)
|
(12)
|
(14)
|
(16)
|
(4)
|
3
|
6
|
(0)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Net Income (Common) |
69
N/A
|
60
-13%
|
74
+23%
|
82
+11%
|
76
-7%
|
79
+4%
|
84
+6%
|
84
+0%
|
83
-1%
|
77
-7%
|
94
+21%
|
98
+4%
|
94
-4%
|
112
+20%
|
122
+8%
|
146
+20%
|
170
+16%
|
175
+3%
|
217
+24%
|
231
+7%
|
239
+3%
|
258
+8%
|
255
-1%
|
260
+2%
|
324
+25%
|
339
+5%
|
232
-32%
|
124
-47%
|
(76)
N/A
|
(147)
-93%
|
(82)
+44%
|
44
N/A
|
21
-52%
|
32
+52%
|
14
-56%
|
(49)
N/A
|
(47)
+5%
|
(43)
+8%
|
(29)
+32%
|
|
| EPS (Diluted) |
0.39
N/A
|
0.25
-36%
|
0.37
+48%
|
0.34
-8%
|
0.35
+3%
|
0.33
-6%
|
0.36
+9%
|
0.36
N/A
|
0.35
-3%
|
0.33
-6%
|
0.4
+21%
|
0.41
+2%
|
0.4
-2%
|
0.5
+25%
|
0.51
+2%
|
0.62
+22%
|
0.72
+16%
|
0.73
+1%
|
0.92
+26%
|
0.98
+7%
|
1
+2%
|
1.07
+7%
|
0.75
-30%
|
0.75
N/A
|
0.94
+25%
|
0.99
+5%
|
0.69
-30%
|
0.4
-42%
|
-0.22
N/A
|
-0.41
-86%
|
-0.23
+44%
|
0.13
N/A
|
0.06
-54%
|
0.09
+50%
|
0.02
-78%
|
-0.12
N/A
|
-0.1
+17%
|
-0.09
+10%
|
-0.06
+33%
|
|
Switch to:
Switch to:
See Also
Discover More
